Search by Drug Name or NDC
NDC 00363-0510-70 Maximum Strength Mucus Relief DM 60; 1200 mg/1; mg/1 Details
Maximum Strength Mucus Relief DM 60; 1200 mg/1; mg/1
Maximum Strength Mucus Relief DM is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by WALGREEN CO.. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 00363-0510-70Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 00363-0510-70Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 00363-0510 |
---|---|
Product ID | 0363-0510_cec3fb6b-1c35-4869-b923-062b12e7e212 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Maximum Strength Mucus Relief DM |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Guaifenesin and Dextromethorphan HBr |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, EXTENDED RELEASE |
Route | ORAL |
Active Ingredient Strength | 60; 1200 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Labeler Name | WALGREEN CO. |
Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA206941 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00363-0510-70 (00363051070)
NDC Package Code | 0363-0510-70 |
---|---|
Billing NDC | 00363051070 |
Package | 4 BLISTER PACK in 1 CARTON (0363-0510-70) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Marketing Start Date | 2017-03-17 |
NDC Exclude Flag | N |
Pricing Information | N/A |